Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase

Neurobiology of Disease

Volumn 13, Issue 2, 2003, Pages 158-166

  Larivière, Roxanne C ^a   Beaulieu, Jean Martin ^a,b   Nguyen, Minh Dang ^a,c   Julien, Jean Pierre ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Intermediate filament; Knockout mice; Mouse models; Peripherin; SOD; Superoxide dismutase 1; Transgenic mice

Indexed keywords

MUTANT PROTEIN; PERIPHERIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; CELL LOSS; ENZYME ANALYSIS; GENETIC LINKAGE; MORTALITY; MOTOR NEURON DISEASE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXICITY; TRANSGENE; UPREGULATION;

EID: 0038386845     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-9961(03)00036-6     Document Type: Article

References (36)

1. Beaulieu J.M., Nguyen M.D., Julien J.P. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147:1999;531-544.
2. Beaulieu J.M., Kriz J., Julien J.P. Induction of peripherin inclusions in brain neurons following mechanical injury and focal cerebral ischemia. Brain Res. 946:2002;153-161.
3. Brody B.A., Ley C.A., Parysek L.M. Selective distribution of the 57kDa neural intermediate filament protein in the rat CNS. J. Neurosci. 9:1989;2391-2401.
4. Bruijn L.I., Becher M.W., Lee V.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:1997;327-338.
5. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1998;1851-1854.
6. Chou S.M. Pathology of motor system disorder. Leigh P.N., Swash M. Motor Neuron Disease Biology and Management . 1995;53-92 Springer-Verlag, London.
7. Corbo M., Hays A.P. Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51:1992;531-537.
8. Couillard-Després S., Zhu Q., Wong P.C., Price D.L., Cleveland D.W., Julien J.P. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. USA. 95:1998;9626-9630.
9. Djabali K., Zissopoulou A., de Hoop M.J., Georgatos S.D., Dotti C.G. Peripherin expression in hippocampal neurons induced by muscle soluble factor(s). J. Cell Biol. 123:1993;1197-1206.
10. Escurat M., Djabali K., Gumpel M., Gros F., Portier M.M. Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecular-mass neurofilament protein (NF-L), during the development of the rat. J. Neurosci. 10:1990;764-784.
11. Gorham J.D., Baker H., Kegler D., Ziff E.B. The expression of the neuronal intermediate filament protein peripherin in the rat embryo. Brain Res. Dev. Brain Res. 57:1990;235-248.
12. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
13. Julien J.P., Beaulieu J.M. Cytosqueletal abnormalities in amyotrophic lateral sclerosis beneficial or detrimental effects? J. Neurol. Sci. 180:2000;7-14.
14. Lacroix S., Rivest S. Functional circuitry in the brain of immune-challenged rats partial involvement of protaglandins . J. Comp. Neurol. 387:1997;307-324.
15. Laflamme N., Lacroix S., Rivest S. An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J. Neurosci. 19:1999;10923-10930.
16. Larivière R.C., Nguyen M.D., Ribeiro-da-Silva A., Julien J.P. Reduced number of unmyelinated sensory axons in peripherin null mice. J. Neurochem. 81:2002;525-532.
17. Lecomte M.J., Basseville M., Landon F., Karpov V., Fauquet M. Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor involvement of STAT proteins . J. Neurochem. 70:1998;971-982.
18. Migheli A., Pezzulo T., Attanasio A., Schiffer D. Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab. Invest. 68:1993;185-191.
19. Morgan T.E., Xie Z., Goldsmith S., Yoshida T., Lanzrein A.S., Stone D., Rozovsky I., Perry G., Smith M.A., Finch C.E. The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience. 89:1999;687-699.
20. Morrison B.M., Janssen W.G., Gordon J.W., Morrison J.H. Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice. J. Comp. Neurol. 391:1998;64-77.
21. Nguyen M.D., Larivière R.C., Julien J.P. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc. Natl. Acad. Sci. USA. 97:2000;12306-12311.
22. Nguyen M.D., Larivière R.C., Julien J.P. Deregulation of Cdk5 in a mouse model of ALS oxicity alleviated by perikaryal neurofilament inclusions . Neuron. 30:2001;135-147.
23. Parysek L.M., Goldman R.D. Distribution of a novel 57 kDa intermediate filament (IF) protein in the nervous system. J. Neurosci. 8:1988;555-563.
24. Ripps M.E., Huntley G.W., Hof P.R., Morrison J.H., Gordon J.W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;689-693.
25. Robertson J., Beaulieu J.M., Doroudchi M.M., Durham H.D., Julien J.P., Mushynski W.E. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J. Cell Biol. 155:2001;217-226.
26. Rosen D.R., Siddique T., Patterson D., Figglewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
27. Sloane J.A., Hollander W., Moss M.B., Rosene D.L., Abraham C.R. Increased microglial activation and protein nitration in white matter of the ageing monkey. Neurobiol. Aging. 20:1999;395-405.
28. Sterneck E., Kaplan D.R., Johnson P.F. Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J. Neurochem. 67:1996;1365-1374.
29. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Natl. Acad. Sci. USA. 93:1996;3155-3160.
30. Williamson T.L., Bruijn L.I., Zhu Q., Anderson K.L., Anderson S.D., Julien J.P., Cleveland D.W. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA. 95:1998;9631-9636.
31. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:1999;50-56.
32. Wong J., Oblinger M.M. Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons. J. Neurosci. Res. 27:1990;332-341.
33. Wong N.K., He B.P., Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol. 59:2000;972-982.
34. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14:1995;1105-1116.
35. Zhang B., Tu P., Abtahian F., Trojanowski J.Q., Lee V.M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139:1997;1307-1315.
36. Zhu Q., Couillard-Despres S., Julien J.P. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148:1997;299-316.